Latin America Veterinary Vaccines Market Report and Forecast 2025-2034
Description
The market size for veterinary vaccines in Latin America reached a value of more than USD 400.77 Million in 2024. The Latin America veterinary vaccines market is expected to grow at a CAGR of 6.50% between 2025 and 2034, reaching a value of USD 752.30 Million by 2034.
Key Trends in the Market
Veterinary vaccines are prescribed and given to animals to improve their health and to prevent the occurrence and transmission of diseases. The different types of vaccines available for veterinary patients are recombinant, modified live virus, and killed virus. Vaccination to animals can also be given through their food or injected to them directly.
Technological advancements such as invention of DNA technology and DNA vaccines have improved the health of animals. New immunisation technologies have been developed that has proved to be very efficient in veterinary vaccines, further fuelling the growth of the market.
Animal owners are becoming aware of new veterinary vaccines as they are the most concerned about their animal’s health. Marking a key trend in the market, more and more people are adopting pets and investing in their vaccinations, supporting the growth of the Latin America veterinary vaccines market.
Key players have been doing research and development to fuel the market growth which has led to the development of recombinant vaccines that have advantages such as non-exposure to the pathogen. Such developments help in the growth of the market.
Market Segmentation
The EMR’s report titled “Latin America Veterinary Vaccines Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Vaccine Type
Livestock vaccines are provided to animals such as cattle, pigs, and poultry, to protect them against illnesses and diseases. Sickness can quickly spread amongst livestock as they are kept together in large numbers, increasing the importance of vaccination and the livestock segment in the Latin America veterinary vaccines market. Lack of vaccination can also lead to increased death rates among livestock, hampering the sales and profits of owners, thereby increasing the demand for vaccinations.
Companion animals such as dogs, cats, and horses are in close proximity to their owners, who often grow strong attachments to the companion animals. This strong attachment drives more pet owners to invest in vaccines for their pets, protecting them from various diseases especially those that are not curable. Vaccination is considered more economical and effective than treatment in many cases.
Market Share by Route of Administration
Parenteral immunisation technique is the most often used means of providing vaccination to animals, including livestock and companion animals. There are three major types of parenteral immunisation, including intramuscular, subcutaneous, and intradermal. The accuracy and effectiveness of parenteral routes of administration has led to hold a leading share in the Latin America veterinary vaccines market.
Oral immunisation is popular for companion animals where pet owners would like to prevent the stress of an injection on their pet. However, oral administration requires pet owners to be highly vigilant to ensure that the vaccine has been consumed properly. New techniques such as mucosal vaccination are expected to witness growth in the forecast period.
Competitive Landscape
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the Latin America veterinary vaccines market covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH founded in 1885 has its headquarter in Germany. It is a research-driven pharmaceutical company that deals with the health of both humans and animals. They discover, develop, manufacture, and then market their innovative products dedicated for healthcare.
Elanco Animal Health Inc.
Elanco Animal Health Inc. is a pharmaceutical company that was established in 1954 and has its headquarters in Indiana, United States. It is an American company which manufactures and supplies medicines and vaccines for pets and farm animals.
Other market players include Biogenesis Bago SA, Benten Biotech SRL, Ourofino Animal Health, VETANCO S.A., SANPHAR, Compañía Cibeles SA, König S.A, and Laboratorios Andoci S.A., among others.
Key Trends in the Market
Veterinary vaccines are prescribed and given to animals to improve their health and to prevent the occurrence and transmission of diseases. The different types of vaccines available for veterinary patients are recombinant, modified live virus, and killed virus. Vaccination to animals can also be given through their food or injected to them directly.
Technological advancements such as invention of DNA technology and DNA vaccines have improved the health of animals. New immunisation technologies have been developed that has proved to be very efficient in veterinary vaccines, further fuelling the growth of the market.
Animal owners are becoming aware of new veterinary vaccines as they are the most concerned about their animal’s health. Marking a key trend in the market, more and more people are adopting pets and investing in their vaccinations, supporting the growth of the Latin America veterinary vaccines market.
Key players have been doing research and development to fuel the market growth which has led to the development of recombinant vaccines that have advantages such as non-exposure to the pathogen. Such developments help in the growth of the market.
Market Segmentation
The EMR’s report titled “Latin America Veterinary Vaccines Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Vaccine Type
- Livestock Vaccines
- Companion Animal Vaccines
- Others
- Oral
- Parenteral
- Others
- Veterinary Hospitals and Clinics
- Pharmacies and Drug Stores
- Online
- Others
- Brazil
- Mexico
- Argentina
- Peru
- Colombia
- Uruguay
- Chile
- Ecuador
- Costa Rica
- The Dominican Republic
- Others
Livestock vaccines are provided to animals such as cattle, pigs, and poultry, to protect them against illnesses and diseases. Sickness can quickly spread amongst livestock as they are kept together in large numbers, increasing the importance of vaccination and the livestock segment in the Latin America veterinary vaccines market. Lack of vaccination can also lead to increased death rates among livestock, hampering the sales and profits of owners, thereby increasing the demand for vaccinations.
Companion animals such as dogs, cats, and horses are in close proximity to their owners, who often grow strong attachments to the companion animals. This strong attachment drives more pet owners to invest in vaccines for their pets, protecting them from various diseases especially those that are not curable. Vaccination is considered more economical and effective than treatment in many cases.
Market Share by Route of Administration
Parenteral immunisation technique is the most often used means of providing vaccination to animals, including livestock and companion animals. There are three major types of parenteral immunisation, including intramuscular, subcutaneous, and intradermal. The accuracy and effectiveness of parenteral routes of administration has led to hold a leading share in the Latin America veterinary vaccines market.
Oral immunisation is popular for companion animals where pet owners would like to prevent the stress of an injection on their pet. However, oral administration requires pet owners to be highly vigilant to ensure that the vaccine has been consumed properly. New techniques such as mucosal vaccination are expected to witness growth in the forecast period.
Competitive Landscape
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the Latin America veterinary vaccines market covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH founded in 1885 has its headquarter in Germany. It is a research-driven pharmaceutical company that deals with the health of both humans and animals. They discover, develop, manufacture, and then market their innovative products dedicated for healthcare.
Elanco Animal Health Inc.
Elanco Animal Health Inc. is a pharmaceutical company that was established in 1954 and has its headquarters in Indiana, United States. It is an American company which manufactures and supplies medicines and vaccines for pets and farm animals.
Other market players include Biogenesis Bago SA, Benten Biotech SRL, Ourofino Animal Health, VETANCO S.A., SANPHAR, Compañía Cibeles SA, König S.A, and Laboratorios Andoci S.A., among others.
Table of Contents
149 Pages
- 1 Executive Summary
- 1.1 Market Size 2024-2025
- 1.2 Market Growth 2025(F)-2034(F)
- 1.3 Key Demand Drivers
- 1.4 Key Players and Competitive Structure
- 1.5 Industry Best Practices
- 1.6 Recent Trends and Developments
- 1.7 Industry Outlook
- 2 Market Overview and Stakeholder Insights
- 2.1 Market Trends
- 2.2 Key Verticals
- 2.3 Key Countries
- 2.4 Supplier Power
- 2.5 Buyer Power
- 2.6 Key Market Opportunities and Risks
- 2.7 Key Initiatives by Stakeholders
- 3 Economic Summary
- 3.1 GDP Outlook
- 3.2 GDP Per Capita Growth
- 3.3 Inflation Trends
- 3.4 Democracy Index
- 3.5 Gross Public Debt Ratios
- 3.6 Balance of Payment (BoP) Position
- 3.7 Population Outlook
- 3.8 Urbanisation Trends
- 4 Country Risk Profiles
- 4.1 Country Risk
- 4.2 Business Climate
- 5 Latin America Veterinary Vaccines Market Analysis
- 5.1 Key Industry Highlights
- 5.2 Latin America Veterinary Vaccines Historical Market (2018-2024)
- 5.3 Latin America Veterinary Vaccines Market Forecast (2025-2034)
- 5.4 Latin America Veterinary Vaccines Market by Vaccine Type
- 5.4.1 Livestock Vaccines
- 5.4.1.1 Historical Trend (2018-2024)
- 5.4.1.2 Forecast Trend (2025-2034)
- 5.4.1.3 Breakup by Type
- 5.4.1.3.1 Porcine Vaccines
- 5.4.1.3.2 Bovine Vaccines
- 5.4.1.3.3 Poultry Vaccines
- 5.4.1.3.4 Others
- 5.4.2 Companion Animal Vaccines
- 5.4.2.1 Historical Trend (2018-2024)
- 5.4.2.2 Forecast Trend (2025-2034)
- 5.4.2.3 Breakup by Type
- 5.4.2.3.1 Canine Vaccines
- 5.4.2.3.2 Feline Vaccines
- 5.4.2.3.3 Equine Vaccines
- 5.4.2.3.4 Others
- 5.4.3 Others
- 5.5 Latin America Veterinary Vaccines Market by Route of Administration
- 5.5.1 Oral
- 5.5.1.1 Historical Trend (2018-2024)
- 5.5.1.2 Forecast Trend (2025-2034)
- 5.5.2 Parenteral
- 5.5.2.1 Historical Trend (2018-2024)
- 5.5.2.2 Forecast Trend (2025-2034)
- 5.5.3 Others
- 5.6 Latin America Veterinary Vaccines Market by Distribution Channels
- 5.6.1 Veterinary Hospitals and Clinics
- 5.6.1.1 Historical Trend (2018-2024)
- 5.6.1.2 Forecast Trend (2025-2034)
- 5.6.2 Pharmacies and Drug Stores
- 5.6.2.1 Historical Trend (2018-2024)
- 5.6.2.2 Forecast Trend (2025-2034)
- 5.6.3 Online
- 5.6.3.1 Historical Trend (2018-2024)
- 5.6.3.2 Forecast Trend (2025-2034)
- 5.6.4 Others
- 5.7 Latin America Veterinary Vaccines Market by Country
- 5.7.1 Brazil
- 5.7.2 Mexico
- 5.7.3 Argentina
- 5.7.4 Peru
- 5.7.5 Colombia
- 5.7.6 Uruguay
- 5.7.7 Chile
- 5.7.8 Ecuador
- 5.7.9 Costa Rica
- 5.7.10 The Dominican Republic
- 5.7.11 Others
- 6 Regional Analysis
- 6.1 Brazil
- 6.1.1 Historical Trend (2018-2024)
- 6.1.2 Forecast Trend (2025-2034)
- 6.2 Mexico
- 6.2.1 Historical Trend (2018-2024)
- 6.2.2 Forecast Trend (2025-2034)
- 6.3 Argentina
- 6.3.1 Historical Trend (2018-2024)
- 6.3.2 Forecast Trend (2025-2034)
- 6.4 Peru
- 6.4.1 Historical Trend (2018-2024)
- 6.4.2 Forecast Trend (2025-2034)
- 6.5 Uruguay
- 6.5.1 Historical Trend (2018-2024)
- 6.5.2 Forecast Trend (2025-2034)
- 6.6 Ecuador
- 6.6.1 Historical Trend (2018-2024)
- 6.6.2 Forecast Trend (2025-2034)
- 6.7 Costa Rica
- 6.7.1 Historical Trend (2018-2024)
- 6.7.2 Forecast Trend (2025-2034)
- 6.8 The Dominican Republic
- 6.8.1 Historical Trend (2018-2024)
- 6.8.2 Forecast Trend (2025-2034)
- 7 Market Dynamics
- 7.1 SWOT Analysis
- 7.1.1 Strengths
- 7.1.2 Weaknesses
- 7.1.3 Opportunities
- 7.1.4 Threats
- 7.2 Porter’s Five Forces Analysis
- 7.2.1 Supplier’s Power
- 7.2.2 Buyer’s Power
- 7.2.3 Threat of New Entrants
- 7.2.4 Degree of Rivalry
- 7.2.5 Threat of Substitutes
- 8 Price Analysis
- 9 Competitive Landscape
- 9.1 Supplier Selection
- 9.2 Key Global Players
- 9.3 Key Regional Players
- 9.4 Key Player Strategies
- 9.5 Company Profiles
- 9.5.1 Boehringer Ingelheim International GmbH
- 9.5.1.1 Company Overview
- 9.5.1.2 Product Portfolio
- 9.5.1.3 Demographic Reach and Achievements
- 9.5.1.4 Certifications
- 9.5.2 Elanco Animal Health Inc.
- 9.5.2.1 Company Overview
- 9.5.2.2 Product Portfolio
- 9.5.2.3 Demographic Reach and Achievements
- 9.5.2.4 Certifications
- 9.5.3 Zoetis Services LLC
- 9.5.3.1 Company Overview
- 9.5.3.2 Product Portfolio
- 9.5.3.3 Demographic Reach and Achievements
- 9.5.3.4 Certifications
- 9.5.4 Biogenesis Bago SA
- 9.5.4.1 Company Overview
- 9.5.4.2 Product Portfolio
- 9.5.4.3 Demographic Reach and Achievements
- 9.5.4.4 Certifications
- 9.5.5 Benten Biotech SRL
- 9.5.5.1 Company Overview
- 9.5.5.2 Product Portfolio
- 9.5.5.3 Demographic Reach and Achievements
- 9.5.5.4 Certifications
- 9.5.6 Ourofino Animal Health
- 9.5.6.1 Company Overview
- 9.5.6.2 Product Portfolio
- 9.5.6.3 Demographic Reach and Achievements
- 9.5.6.4 Certifications
- 9.5.7 VETANCO S.A.
- 9.5.7.1 Company Overview
- 9.5.7.2 Product Portfolio
- 9.5.7.3 Demographic Reach and Achievements
- 9.5.7.4 Certifications
- 9.5.8 SANPHAR
- 9.5.8.1 Company Overview
- 9.5.8.2 Product Portfolio
- 9.5.8.3 Demographic Reach and Achievements
- 9.5.8.4 Certifications
- 9.5.9 Compañía Cibeles SA
- 9.5.9.1 Company Overview
- 9.5.9.2 Product Portfolio
- 9.5.9.3 Demographic Reach and Achievements
- 9.5.9.4 Certifications
- 9.5.10 König S.A
- 9.5.10.1 Company Overview
- 9.5.10.2 Product Portfolio
- 9.5.10.3 Demographic Reach and Achievements
- 9.5.10.4 Certifications
- 9.5.11 Laboratorios Andoci, S.A.
- 9.5.11.1 Company Overview
- 9.5.11.2 Product Portfolio
- 9.5.11.3 Demographic Reach and Achievements
- 9.5.11.4 Certifications
- 9.5.12 Others
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
